Valley National Advisers’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $166K | Sell |
3,884
-546
| -12% | -$24.4K | 0.02% | 281 |
|
|
2026
Q1 | $213K | Hold |
4,430
| – | – | 0.03% | 242 |
|
|
2025
Q4 | $214K | Sell |
4,430
-1,295
| -23% | -$64.2K | 0.03% | 237 |
|
|
2025
Q3 | $270K | Sell |
5,725
-28
| -0.5% | -$1.35K | 0.04% | 202 |
|
|
2025
Q2 | $277K | Sell |
5,753
-472
| -8% | -$24.1K | 0.05% | 210 |
|
|
2025
Q1 | $345K | Sell |
6,225
-617
| -9% | -$33.4K | 0.06% | 192 |
|
|
2024
Q4 | $329K | Sell |
6,842
-3,036
| -31% | -$154K | 0.06% | 193 |
|
|
2024
Q3 | $569K | Sell |
9,878
-747
| -7% | -$40.3K | 0.1% | 156 |
|
|
2024
Q2 | $515K | Sell |
10,625
-729
| -6% | -$35.2K | 0.08% | 156 |
|
|
2024
Q1 | $551K | Sell |
11,354
-621
| -5% | -$30.3K | 0.08% | 153 |
|
|
2023
Q4 | $595K | Buy |
11,975
+55
| +0.5% | +$2.69K | 0.09% | 145 |
|
|
2023
Q3 | $639K | Sell |
11,920
-26
| -0.2% | -$1.39K | 0.11% | 133 |
|
|
2023
Q2 | $644K | Sell |
11,946
-488
| -4% | -$26.3K | 0.11% | 141 |
|
|
2023
Q1 | $704K | Hold |
12,434
| – | – | 0.12% | 137 |
|
|
2022
Q4 | $606K | Buy |
12,434
+762
| +7% | +$33.4K | 0.11% | 147 |
|
|
2022
Q3 | $467K | Sell |
11,672
-1,022
| -8% | -$45.5K | 0.1% | 168 |
|
|
2022
Q2 | $637K | Hold |
12,694
| – | – | 0.13% | 133 |
|
|
2022
Q1 | $652K | Hold |
12,694
| – | – | 0.12% | 150 |
|
|
2021
Q4 | $636K | Buy |
12,694
+128
| +1% | +$6.33K | 0.12% | 148 |
|
|
2021
Q3 | $606K | Buy |
12,566
+22
| +0.2% | +$1.12K | 0.11% | 146 |
|
|
2021
Q2 | $661K | Sell |
12,544
-227
| -2% | -$11.8K | 0.12% | 140 |
|
|
2021
Q1 | $632K | Sell |
12,771
-498
| -4% | -$23.9K | 0.12% | 138 |
|
|
2020
Q4 | $645K | Hold |
13,269
| – | – | 0.14% | 124 |
|
|
2020
Q3 | $666K | Sell |
13,269
-90
| -0.7% | -$4.63K | 0.15% | 100 |
|
|
2020
Q2 | $682K | Buy |
13,359
+47
| +0.4% | +$2.28K | 0.16% | 97 |
|
|
2020
Q1 | $582K | Sell |
13,312
-586
| -4% | -$28K | 0.16% | 102 |
|
|
2019
Q4 | $698K | Buy |
13,898
+119
| +0.9% | +$5.58K | 0.17% | 103 |
|
|
2019
Q3 | $638K | Sell |
13,779
-100
| -0.7% | -$4.31K | 0.17% | 101 |
|
|
2019
Q2 | $601K | Sell |
13,879
-711
| -5% | -$30.2K | 0.17% | 106 |
|
|
2019
Q1 | $646K | Sell |
14,590
-264
| -2% | -$11.3K | 0.19% | 98 |
|
|
2018
Q4 | $645K | Buy |
14,854
+117
| +0.8% | +$5.16K | 0.21% | 90 |
|
|
2018
Q3 | $658K | Buy |
14,737
+686
| +5% | +$29.3K | 0.23% | 95 |
|
|
2018
Q2 | $562K | Sell |
14,051
-265
| -2% | -$10.4K | 0.21% | 101 |
|
|
2018
Q1 | $574K | Sell |
14,316
-1,043
| -7% | -$43.4K | 0.21% | 96 |
|
|
2017
Q4 | $660K | Sell |
15,359
-263
| -2% | -$12.1K | 0.23% | 85 |
|
|
2017
Q3 | $778K | Buy |
15,622
+25
| +0.2% | +$1.21K | 0.27% | 68 |
|
|
2017
Q2 | $747K | Sell |
15,597
-237
| -1% | -$11.3K | 0.27% | 67 |
|
|
2017
Q1 | $716K | Buy |
15,834
+11,804
| +293% | +$501K | 0.27% | 69 |
|
|
2016
Q4 | $163K | Sell |
4,030
-11,808
| -75% | -$465K | 0.07% | 154 |
|
|
2016
Q3 | $605K | Buy |
15,838
+653
| +4% | +$26.2K | 0.31% | 86 |
|
|
2016
Q2 | $635K | Buy |
15,185
+1,625
| +12% | +$66.6K | 0.33% | 82 |
|
|
2016
Q1 | $545K | Buy |
13,560
+3,911
| +41% | +$157K | 0.29% | 89 |
|
|
2015
Q4 | $412K | Sell |
9,649
-4,099
| -30% | -$189K | 0.24% | 94 |
|
|
2015
Q3 | $653K | Buy |
13,748
+737
| +6% | +$37.5K | 0.4% | 74 |
|
|
2015
Q2 | $644K | Buy |
13,011
+3,212
| +33% | +$163K | 0.36% | 77 |
|
|
2015
Q1 | $484K | Buy |
9,799
+9,166
| +1,448% | +$438K | 0.29% | 89 |
|
|
2014
Q4 | $34K | Buy |
+633
| New | +$30.7K | 0.03% | 197 |
|
Other funds holding SNY
MIP
BIP
Valley National Advisers's SNY Position: Q2 2026 in Review
Valley National Advisers reduced its Sanofi (SNY) stake by 12% in Q2 2026, selling an estimated $24.4K and leaving 3,884 shares worth $166K. The position accounts for 0.02% of the portfolio, ranked #281.
Valley National Advisers first reported a position in SNY in Q4 2014 and has held it in 47 quarters since. The position peaked at $778K in Q3 2017. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.
- Valley National Advisers held 3,884 shares of Sanofi worth $166K as of Q2 2026.
- Valley National Advisers sold 546 Sanofi shares in Q2 2026, an estimated $24.4K.
- Sanofi made up 0.02% of Valley National Advisers's portfolio in Q2 2026, its #281 holding.
- Valley National Advisers first reported a position in Sanofi in Q4 2014 and has held it in 47 quarters since.
- Valley National Advisers's Sanofi position peaked at $778K in Q3 2017.
- 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.
Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.